Join Index
For Startups
For Investors
For Brands
For Analysts
Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Pricing
Data Tools
Innovation Services
About Index
Index
By TNW
Log in
Register
Apothecary Capital
0
Apothecary Capital
Suggest edits
Overview
News
Investments
3
Portfolio
Portfolio Tracker
Add info
Xconomy
FibroGen Pushes Forward With Anemia Pill in China, But Big Test Awaits
Health
Science
$62,000,000
Post-IPO equity
biospace
FibroGen Gets 62 Million License Payment from Partner AstraZeneca PLC
Health
Science
